I build open-source solutions at the intersection of computational biology, artificial intelligence, and rare disease, from tools that read unknown variants to products people can actually use. Every idea moves from code to real-world impact, guided by direct collaboration with researchers, clinicians, foundations, and families around the world.
Selected work